Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The MILE Study: Deferasirox for Iron Overload
NCT00673608Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2007
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of deferasirox in Transfusional Iron Overload (TIO), sponsored by Novartis. Started Nov 2007; status: completed.
02
Drugs
deferasirox
03
Conditions
Transfusional Iron Overload (TIO)
Beyond the preview
Go deeper on NCT00673608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673608.